PharmaTalkRadio

At Dpharm US 2015, Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly hosted a talk show on MakingClinical Trials a Care Option for Patients to fantastic reviews. Valerie Bowling, producer welcomes Katherine as she hosts a similar session on Pharma Talk Radio. About the Show: This talk demonstrates how an organized multispecialty healthcare system, clinical research site network and...

In this episode of Pharma Talk Radio, we feature medical oncologist, Dr Anna Pavlick, Director of the Melanoma Program at the NYU Cancer Institute on Safety Elements of Cancer Immunotherapies. Dr Pavlick originally gave this presentation in June 2015 at the IO360 conference.  Her talk focuses on immune related adverse affects of immuno therapy. More specifically, she covers: •    Identifying warni...

At the May 2015 Chief Medical Officer’s Summit in Boston, we featured a session on: How the Availability of Capital Impacts the Role of the CMO In this session, the panelists cover: Optimal use of the proceeds Determining a development path, new molecules vs. new studies on the same molecules Appropriate stewardship of the capital Balancing short-term and long-term objectives; particularly when th...

At the May 2015 Chief Medical Officer's Summit in Boston, we featured a session on: How Investors Assess R&D Biotech Management Take a look at the details below: In this session, we begin with a presentation on a perspective on the method of evaluating a disease space, which includes a comprehensive understanding of 1) the science, 2) the competitive landscape and 3) the management teams for e...

At the Conference Forum's 2015 Chief Medical Officer's Summit in Boston, David Schenkein, MD, CEO, Agios provided a warm and personal keynote sharing his journey as a Physican CEO. In this recording of the session, gain an insight into Dr Schenkein's views on leadership in running a biotech company and more specifically: The journeyThe people and mentorshipsPrioritizing resourcesSuccesses and fail...

Clinical Air Episode #14 is pleased to present a discussion on Consumer Electronics in Clinical Research. Craig Lipset, Head of Clinical Innovation R&D at Pfizer welcomes guests from Rebar Interactive and Eli Lilly to address and explore an update on what's available, what's capable and what's working with consumer electronics in clinical research. We explore topics including, but not limited...

The last 30 years of Immuno-Oncology research have provided strong evidence that tumors do recognize the immune system and their development can be stopped or controlled long term. Given the impressive survival data over the past five years, it is not surprising that Immuno-Oncology is arguably the most exciting area in the advancement of science and patient care today.  However, with all research...

Design Thinking is a human centered approach to innovation that helps uncover the sweet spot of opportunity where the needs of people, the possibilities of technology and the requirements for business success all converge. The application of the Design Thinking methodology (originating out of Stanford’s d. School) as a new approach to looking at solutions can lead to disruptive innovation in clini...

In September 2012, TransCelerate Biopharma launched with the aim of simplifying and accelerating the delivery of innovative medicines to patients.  What progress has really been made and what are the realistic goals for 2015? In our 2015 kick off radio show, Clinical Air Episode #13, host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer talks with Dalvir Gill, PhD, CEO of Transcelerate a...

Since the FDA and EMA published their current thinking on clinical oversight and risk-based monitoring (RBM) strategies, the topic has received a magnitude of attention, commanding column inches, webinar discussions and industry conferences. With so much discussion going on, it is unsurprising that many sponsors are feeling out in the cold when it comes to identifying how to practically implement...

In Clinical Air Episode #12, Craig Lipset, Head of Clinical Innovation, R&D, Pfizer talks with Marc Sluijs, Director Life Science Business Development at Oracle Health Sciences.  Marc shares his thoughts on the digital health space and where technology is heading in clinical trials. In this informal discussion, Craig and Marc also cover how digital technologies can better serve patients as wel...

Donald Jones, Chief Digital Officer, Scripps Translational Science Institute talks with host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer on what's happening with digital in drug development. Don discusses his thoughts on the evolution of new products with digital and the “digitazation” of tools for clinical trials. He also shares his thoughts on the biggest disruptors in pharma.  Do...

Join host, Craig H. Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion on what it really means to partner with patients in clinical trials. Guests include: Jeri Burtchell, Founder, Partners in Research Regina Holliday, Artist and Medical Advocate For more information on Jeri's new launch, visit: Healthivibe.com and for Regina walking gallary, google Regina Holliday, walking gal...

Join host, Craig Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion onInvesting in the future of clinical research. Guests include: Todd Pietri, Co-Founder, Milestone Ventures Jeremy Sohn, Managing Director, MPM Capital  VC views on: Disruption in the clinical trial spaceEntrepreneursFinding opportunities (incubators and accelerators)Good sources of deal flowsInvesting in techn...

In Clinical Air episode # 8, host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer hosts a show discussing investigators as partners in clinical research. Guests include: Christine Pierre, President, Society of Clinical Research Jacalyn Kent, Director, Clinical Development Information & Optimization, Eli Lilly Key topics include:  Misunderstandings around Remote Based Monitoring Trai...

In 2013 Pfizer launched the Pfizer Blue Button Project, a first-of-it’s-kind initiative enabling patients who have participated in clinical trials the opportunity to download their individual clinical data.  Using the Blue Button standard launched by the White House, patients will be empowered to use the data to improve their overall health and wellness, from sharing with healthcare providers to p...

How a patient experiences a clinical trial is changing. Access, ease, efficiencey, safety and better quality data collection are the target goals. This episode features some of the emerging technologies together with a discussion on the opportunities and challenges to include patient access, recruitment and retention. Predictions for 2014 are shared by our guests. Host: Craig H. Lipset, MBA Head o...

Join guests Kerri Weingard, ANP, COO, Verified Clinical Trials and Susan Salgado, PhD, Founder, Hospitality Quotient as they identify the barriers and limitations in engaging patients in clinical trials. What we can do about it through communication and service? Hosted by Valerie Bowling, Executive Director, the Conference Forum, this episode addresses one of the hottest topics at the Patients as...

This episode provides a recap on what's happening with mobile/sensors in clinical trials especially as they affect patients. Host: Craig Lipset, Head of Clinical Innovation, R&D, Pfizer, Inc.  Guests: Tim Davis, CEO & Co-Founder, Exco InTouch Abbe Steel, Vice President of Patient & Physician Services, UBC 

Eli Lilly and Quintiles entered into a co-investment partnership to develop a new solution using computer-assisted designs that emphasize the improvement of scientific and operational outcomes of clinical trials. The results were shared at the DPharm 2013 event and project leaders from both companies will talk to our host Craig Lipset on how this formation is doing a year later. Also joining Craig...

A panel of executives from leading pharma and the venture capital community at the DPharm Disruptive Innovations conference recently awarded the 2013 Disruptive Innovator of the Year title to Medidata Solutions and Spaulding Clinical Research. They won for their collaboration on a novel study evaluating the impact of mobile and cloud-based technology on patient engagement for improved health outco...

Join us in a discussion on serving patients in clinical trials. Making clinical trials more accessible for patients Emerging technologies / iPads and informed consent Disruption Headlines in the news Host: Craig Lipset, MBA Head of Clinical Innovation, R&D, Pfizer Inc. Guests: Andreas Koester, MD, PhD VP, Clinical Trial Innovation & External Alliances,  Janssen Anthony Costello, CEO, Mytru...

The CMO of a biotech is like no other job in the world. The CMO is not only responsible for delivering on clinical trials, but also is a key player in the company's fundraising efforts.   From the Chief Medical Officer Summit, please join co-chairs Dr. Greg Fiore, CMO of the The Medicines Company and Dr. Steven Zelenkofske, CMO of Regado together with opening presenter Dr. Tyler Martin, CMO &...

Drs. Christopher Gallen, CEO at SK BioPharmaceuticals and Mitchell Katz, Executive Director, Medical Research Operations at Purdue Pharma, in a candid conversation on navigating the complexities of Global Clinical Trials and addressing topics including: Why global trials? Why are global trials so expensive? How are companies re-thinking global trials? What's happening with global outsourcing? Thou...

Join host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer with guests Joe Kim, Clinical Operations Director, Shire and Dr. Hugo Stevenson, physician and serial entrepreneur, as they discuss innovation transforming the clinical trial space to include:   *   Mobile technology and apps   *   Clinical trials and diversity   *   Google Glass for health   *   Investigator database sharing   *...